Título Does curcumin improve liver enzymes levels in nonalcoholic fatty liver disease? A systematic review, meta-analysis, and meta-regression
Autores Aragon-Vela, Jeronimo , Sanchez-Oliver, Antonio J. , Huertas, Jesus R. , CASUSO PÉREZ, RAFAEL
Publicación externa No
Medio PHYTOTHERAPY RESEARCH
Alcance Review
Naturaleza Científica
Cuartil JCR 1
Cuartil SJR 1
Web https://www.scopus.com/inward/record.uri?eid=2-s2.0-85197910286&doi=10.1002%2fptr.8274&partnerID=40&md5=18580b784454948d2862f896bd135eb7
Fecha de publicacion 01/08/2024
ISI 001263035300001
Scopus Id 2-s2.0-85197910286
DOI 10.1002/ptr.8274
Abstract The aim of this meta-analysis is to investigate the sources of heterogeneity in randomized clinical trials examining the effects of curcumin supplementation on liver aminotransferases in subjects with nonalcoholic fatty liver disease (NAFLD). We conducted a systematic search of the PubMed, SCOPUS, and Web of Science databases for randomized clinical trials and identified 15 studies (n = 835 subjects). We used random-effects models with DerSimonian-Laird methods to analyze the serum levels of alanine aminotransferase and aspartate aminotransferase enzymes. Our results indicate that curcumin did not affect serum alanine aminotransferase, but it did reduce aspartate aminotransferase levels. Notably, both outcomes showed high heterogeneity (p < 0.01). Subgroup analysis revealed that adding piperine to curcumin did not benefit aminotransferase levels in NAFLD patients. Additionally, we found a negative correlation between the duration of the intervention and the relative (mg/kg/day) curcumin dose with the reduction in liver aminotransferases. In summary, the sources of heterogeneity identified in our study are likely attributed to the duration of the intervention and the relative dose of curcumin. Consequently, longer trials utilizing high doses of curcumin could diminish the positive impact of curcumin in reducing serum levels of aminotransferases in patients with NAFLD.
Palabras clave aminotransferases; nonalcoholic fatty liver disease; obesity; piperine; polyphenol
Miembros de la Universidad Loyola

Change your preferences Gestionar cookies